{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:03:04Z","timestamp":1790337784210,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103587","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:12:16Z","timestamp":1787242336000},"page":"103587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Endolysosomal routing combined with immune stimulation enhances anti-tumor efficacy of an HPV16 mRNA therapeutic vaccine"],"prefix":"10.1016","volume":"40","author":[{"given":"Wenjie","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9296-4511","authenticated-orcid":false,"given":"Jingshu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-3435","authenticated-orcid":false,"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103587_bib1","first-page":"322","article-title":"Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022","volume":"5","author":"Wu","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.mtbio.2026.103587_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2026.103587_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12967-025-06470-x","article-title":"Human papilloma virus (HPV) mediated cancers: an insightful update","volume":"23","author":"Baba","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mtbio.2026.103587_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mtbio.2026.103587_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ijc.29019","article-title":"Judging the carcinogenicity of rare human papillomavirus types","volume":"136","author":"Combes","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mtbio.2026.103587_bib7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/ijgc-2022-003801","article-title":"Proportions and incidence of locally advanced cervical cancer: a global systematic literature review","volume":"32","author":"Monk","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103587_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267571","article-title":"Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis","volume":"17","author":"Tekalign","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.mtbio.2026.103587_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2024.04.027","article-title":"A systematic review of stage IVA cervical cancer treatment: challenges in the management of an understudied group","volume":"187","author":"Hunsberger","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103587_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pvr.2017.12.006","article-title":"Therapeutic vaccines for high-risk HPV-associated diseases","volume":"5","author":"Chabeda","year":"2018","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.mtbio.2026.103587_bib12","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fmicb.2019.03116","article-title":"Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy","volume":"10","author":"Pal","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mtbio.2026.103587_bib13","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.str.2024.09.011","article-title":"Structural biology of the human papillomavirus","volume":"32","author":"Han","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.mtbio.2026.103587_bib14","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1128\/JVI.02188-07","article-title":"The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth","volume":"82","author":"Spanos","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.mtbio.2026.103587_bib15","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1073\/pnas.1435900100","article-title":"Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter","volume":"100","author":"Veldman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103587_bib16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.103587_bib17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/ijc.25474","article-title":"Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways","volume":"128","author":"Smeets","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mtbio.2026.103587_bib18","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/emboj\/18.9.2449","article-title":"The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth","volume":"18","author":"Brehm","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.mtbio.2026.103587_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.909223","article-title":"Prophylactic and therapeutic HPV vaccines: current scenario and perspectives","volume":"12","author":"Mo","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.mtbio.2026.103587_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.mtbio.2026.103587_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12985-024-02397-9","article-title":"The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)","volume":"21","author":"Movahed","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.mtbio.2026.103587_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70434","article-title":"mRNA vaccines: current applications and future directions","volume":"6","author":"Li","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.mtbio.2026.103587_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103587_bib24","series-title":"Therapeutic Rna for hpv-positive Cancer","author":"Sahin","year":"2022"},{"key":"10.1016\/j.mtbio.2026.103587_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/genes16040376","article-title":"The bright future of mRNA as a therapeutic molecule","volume":"16","author":"V\u00e9lez","year":"2025","journal-title":"Genes"},{"key":"10.1016\/j.mtbio.2026.103587_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/biom15060897","article-title":"Signal peptides: from molecular mechanisms to applications in protein and vaccine engineering","volume":"15","author":"Zhang","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.mtbio.2026.103587_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.074","article-title":"An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity","volume":"381","author":"Ling","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103587_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1096\/fj.08-115055","article-title":"Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates","volume":"23","author":"Verhoef","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.mtbio.2026.103587_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.180.1.309","article-title":"Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals","volume":"180","author":"Kreiter","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103587_bib30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ni989","article-title":"Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain","volume":"4","author":"Liz\u00e9e","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mtbio.2026.103587_bib31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/biomedicines11030796","article-title":"Immortalized B cells transfected with mRNA of antigen fused to MITD (IBMAM): an effective tool for antigen-specific T-Cell expansion and TCR validation","volume":"11","author":"Wang","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.mtbio.2026.103587_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000258","article-title":"HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression","volume":"8","author":"Chen","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103587_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10245330410001701549","article-title":"Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines","volume":"9","author":"Chang","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.mtbio.2026.103587_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41586-025-08758-w","article-title":"STING agonist-based ER-targeting molecules boost antigen cross-presentation","volume":"641","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103587_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115711","article-title":"Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironment","volume":"9","author":"Song","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mtbio.2026.103587_bib36","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/j.1582-4934.2008.00531.x","article-title":"A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities","volume":"13","author":"Provenzano","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.mtbio.2026.103587_bib37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.molimm.2011.01.006","article-title":"Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: implications for vaccine development","volume":"48","author":"Kovjazin","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.mtbio.2026.103587_bib38","article-title":"MHC class I trafficking signal improves induction of cytotoxic T lymphocyte using artificial antigen presenting cells","volume":"41","author":"Sasaki","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"issue":"Suppl 2","key":"10.1016\/j.mtbio.2026.103587_bib39","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1007\/BF01705031","article-title":"The side-effect profile of GM-CSF","volume":"20","author":"Stern","year":"1992","journal-title":"Infection"},{"key":"10.1016\/j.mtbio.2026.103587_bib40","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1016\/j.vaccine.2014.06.060","article-title":"Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus \u0394VP8* subunit parenteral vaccines","volume":"32","author":"Wen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.mtbio.2026.103587_bib41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/315324","article-title":"Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins","volume":"181","author":"Diethelm-Okita","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mtbio.2026.103587_bib42","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s40265-022-01761-9","article-title":"Cadonilimab: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.mtbio.2026.103587_bib43","article-title":"SHR-1701 in combination with platinum-based chemotherapy and BP102 (a bevacizumab biosimilar) for persistent, recurrent, or metastatic cervical cancer: data from a phase 1b\/3 study","volume":"41","author":"Liu","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103587_bib44","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1158\/1078-0432.CCR-22-0346","article-title":"SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF\u03b2, for recurrent or metastatic cervical cancer: a clinical expansion cohort of a phase I study","volume":"28","author":"Feng","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103587_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000612","article-title":"Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine","volume":"8","author":"Smalley Rumfield","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103587_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1426519","article-title":"M7824, a novel bifunctional anti-PD-L1\/TGF\u03b2 Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine","volume":"7","author":"Knudson","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.mtbio.2026.103587_bib47","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1073\/pnas.1908158117","article-title":"High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model","volume":"117","author":"Luchtel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103587_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpobgyn.2017.09.008","article-title":"Therapeutic HPV vaccines","volume":"47","author":"Hancock","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.mtbio.2026.103587_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241238629","article-title":"Advancements in mRNA vaccines: a promising approach for combating human papillomavirus-related cancers","volume":"31","author":"Iqbal","year":"2024","journal-title":"Cancer Control"},{"key":"10.1016\/j.mtbio.2026.103587_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1629259","article-title":"HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory","volume":"8","author":"Grunwitz","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.mtbio.2026.103587_bib51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103587_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-3083.2012.02719.x","article-title":"Enhanced cellular immune response elicited by a DNA vaccine fused with Ub against Mycobacterium tuberculosis","volume":"76","author":"Wang","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103587_bib53","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2007.11.034","article-title":"Antigen-specific CD8+ T cells induced by the ubiquitin fusion degradation pathway","volume":"365","author":"Imai","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mtbio.2026.103587_bib54","article-title":"Synergistic innate immune activation and anti-tumor immunity through combined STING and TLR4 stimulation","volume":"2024","author":"Higgs","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.mtbio.2026.103587_bib55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10238-025-01838-1","article-title":"Unlocking the therapeutic potential of the STING signaling pathway in anti-tumor treatment","volume":"25","author":"Li","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.mtbio.2026.103587_bib56","first-page":"13","article-title":"Clinical uses of GM-CSF, a critical appraisal and update","volume":"2","author":"Arellano","year":"2008","journal-title":"Biologics"},{"key":"10.1016\/j.mtbio.2026.103587_bib57","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.31219","article-title":"PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine","volume":"142","author":"Shi","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mtbio.2026.103587_bib58","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4049\/jimmunol.1500861","article-title":"G-CSF and GM-CSF in neutropenia","volume":"195","author":"Mehta","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103587_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1600-065X.2002.18813.x","article-title":"GM-CSF-based cancer vaccines","volume":"188","author":"Dranoff","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.mtbio.2026.103587_bib60","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.mtbio.2026.103587_bib61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-022-06562-y","article-title":"The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II-III and metastatic breast cancers","volume":"194","author":"Anderson","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mtbio.2026.103587_bib62","first-page":"52","article-title":"GM-CSF-secreting vaccines for solid tumors: moving forward","volume":"10","author":"Gupta","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.mtbio.2026.103587_bib63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/mmt-2016-0021","article-title":"Talimogene laherparepvec: overview, combination therapy and current practices","volume":"3","author":"O'Donoghue","year":"2016","journal-title":"Melanoma Manag"},{"key":"10.1016\/j.mtbio.2026.103587_bib64","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41565-024-01624-2","article-title":"Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways","volume":"19","author":"Wang","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.103587_bib65","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.3390\/ijms26178716","article-title":"DNA vaccines in the Post-mRNA era: engineering, applications, and emerging innovations","volume":"26","author":"Neeli","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103587_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153604","article-title":"Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicity","volume":"132","author":"Ren","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mtbio.2026.103587_bib66","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1073\/pnas.1101262108","article-title":"Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming","volume":"108","author":"Kochan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103587_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/hum.2021.197","article-title":"Modulating oncolytic adenovirus immunotherapy by driving two axes of the immune system by expressing 4-1BBL and CD40L","volume":"33","author":"Lu","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mtbio.2026.103587_bib69","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259000642600832X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259000642600832X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:30:34Z","timestamp":1790335834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259000642600832X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"alternative-id":["S259000642600832X"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103587","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endolysosomal routing combined with immune stimulation enhances anti-tumor efficacy of an HPV16 mRNA therapeutic vaccine","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103587"}}